83 related articles for article (PubMed ID: 16681759)
1. Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas.
Chen TH; Fukuhara K; Mandai M; Matsumura N; Kariya M; Takakura K; Fujii S
Int J Gynecol Cancer; 2006; 16(2):772-9. PubMed ID: 16681759
[TBL] [Abstract][Full Text] [Related]
2. High cyclooxygenase-2 expression in cervical adenocarcinomas.
Chen YJ; Wang LS; Wang PH; Lai CR; Yen MS; Ng HT; Yuan CC
Gynecol Oncol; 2003 Mar; 88(3):379-85. PubMed ID: 12648590
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer.
Suemori T; Susumu N; Iwata T; Banno K; Yamagami W; Hirasawa A; Sugano K; Matsumoto E; Aoki D
Int J Gynecol Cancer; 2015 Sep; 25(7):1165-72. PubMed ID: 26111272
[TBL] [Abstract][Full Text] [Related]
4. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
5. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Kim HS; Min KW
Gynecol Oncol; 2004 Dec; 95(3):523-9. PubMed ID: 15581957
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.
Kim JY; Lim SJ; Park K; Lee CM; Kim J
Gynecol Oncol; 2005 May; 97(2):337-41. PubMed ID: 15863127
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.
Fujimoto J; Toyoki H; Sato E; Sakaguchi H; Jahan I; Alam SM; Tamaya T
J Biomed Sci; 2006 Nov; 13(6):825-32. PubMed ID: 17013750
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.
Manchana T; Triratanachat S; Sirisabya N; Vasuratna A; Termrungruanglert W; Tresukosol D
Gynecol Oncol; 2006 Mar; 100(3):556-60. PubMed ID: 16246405
[TBL] [Abstract][Full Text] [Related]
11. Epithelial and tumor-associated endothelial expression of B7-H3 in cervical carcinoma: relation with CD8+ intraepithelial lymphocytes, FIGO stage, and phosphohistone H3 (PHH3) reactivity.
Brustmann H; Igaz M; Eder C; Brunner A
Int J Gynecol Pathol; 2015 Mar; 34(2):187-95. PubMed ID: 25675190
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
13. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group.
Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH
Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514
[TBL] [Abstract][Full Text] [Related]
15. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
Luo CF; Zhu RQ; Wang H; Lu YL
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
17. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in cervical squamous cell carcinoma: the significance of expression in neoplastic cells within the lymphovascular space.
Settakorn J; Khunamornpong S; Sukpan K; Srisomboon J; Siriaungkul S
Asian Pac J Cancer Prev; 2009; 10(6):1011-4. PubMed ID: 20192574
[TBL] [Abstract][Full Text] [Related]
20. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
